CSPC to launch Paxlovid version in China; SEC charges ex-Pfizer employee with insider trading
Pfizer inked a deal with a Chinese pharma to launch a form of its Covid-19 antiviral Paxlovid in China. The company is working with CSPC
Pfizer inked a deal with a Chinese pharma to launch a form of its Covid-19 antiviral Paxlovid in China. The company is working with CSPC
After her controversial nomination by Alex Denner to Biogen’s board, Susan Langer was elected this week with fewer votes than any other member of the
The European Commission struck deals with a handful of contractors, including Pfizer, to secure “sufficient and agile manufacturing capacities” for a variety of vaccine types
Trypanosomes look like microscopic one-celled eels, but instead of water, some of the parasites swim in blood and others dive in and out of cells.
Genfit and Ipsen announced Friday morning that their experimental treatment elafibranor helped patients with primary biliary cholangitis, a rare liver disease, see a decrease in
Cancer biotech Intensity Therapeutics launched an IPO as it aims to advance a therapy being tested in sarcoma and breast cancer. The Connecticut biotech announced
Madrigal Pharmaceuticals kicked off the regulatory review process for its experimental NASH treatment as it pursues the first FDA approval to treat the debilitating and
Life sciences VC firm Westlake Village BioPartners is ready to restock its capital reserves shortly after its success with bringing portfolio company Acelyrin to one
Cyteir Therapeutics will dissolve, liquidate and return remaining cash to shareholders, the Lexington, MA-based biotech said Friday morning. The public company said its investigational drug
The Centers for Medicare and Medicaid Services on Friday took aim at lawsuits filed against its incoming drug price negotiations, with new final guidance on